Business Context and Reporting Period
Milestone Scientific Inc. (MLSS) filed a Form 8-K on July 24, 2026, reporting a corporate event under Item 8.01 (Other Events). The company is incorporated in Delaware and trades on the NYSE American.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or general liquidity metrics. The only financial data disclosed relates to specific debt instruments:
- Convertible Bridge Notes: Originally issued in an aggregate principal amount of $800,000.
- Outstanding Principal Subject to Conversion:
- Benedetta Casamento: $116,495.47
- Dr. Didier Demesmin: $58,247.73
- Neal Goldman: $291,238.66
Material Changes
Three directors (Casamento, Demesmin, and Goldman) submitted Conversion Notices to convert the remaining outstanding principal and accrued interest of their Convertible Bridge Notes into shares of common stock. These notes were partially converted previously in connection with a private placement that closed on April 20, 2026.
Guidance, Outlook, and Conditions
Conversion Conditions: The conversions will become effective automatically only when two conditions are met:
- The Fair Value of the Common Stock is not less than $0.50 per share.
- The applicable Holder is permitted to buy and sell securities in compliance with the Company's Insider Trading Policy.
Investor Verification Checklist
- Verify the current trading price of MLSS common stock to determine if the $0.50 per share conversion threshold has been met.
- Confirm the total number of shares to be issued upon conversion once the conditions are satisfied.
- Review the company's Insider Trading Policy to ensure the directors are eligible to trade.
- Check subsequent filings for the actual issuance of shares and the resulting dilution impact.